RBM43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.346000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.232800E-01
Normal-vs-Stage2
4.068400E-02
Normal-vs-Stage3
1.454820E-01
Normal-vs-Stage4
3.739000E-01
Stage1-vs-Stage2
6.361800E-01
Stage1-vs-Stage3
5.410400E-02
Stage1-vs-Stage4
6.162400E-01
Stage2-vs-Stage3
1.61593999999932E-05
Stage2-vs-Stage4
3.622200E-01
Stage3-vs-Stage4
6.403000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.121700E-02
Normal-vs-AfricanAmerican
2.976000E-01
Normal-vs-Asian
2.269200E-01
Caucasian-vs-AfricanAmerican
4.096400E-01
Caucasian-vs-Asian
8.236600E-01
AfricanAmerican-vs-Asian
7.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.327600E-02
Normal-vs-Female
3.147800E-02
Male-vs-Female
7.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.391590E-01
Normal-vs-Age(41-60Yrs)
8.389900E-02
Normal-vs-Age(61-80Yrs)
2.952400E-02
Normal-vs-Age(81-100Yrs)
3.808000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.287200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.391200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.801800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.755500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.975380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.174600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.858290E-02
Normal-vs-Daily Drinker
1.724070E-02
Normal-vs-Weekly Drinker
5.543700E-02
Normal-vs-Occasional Drinker
2.074200E-01
Normal-vs-Social Drinker
1.328770E-01
Non Drinker-vs-Daily Drinker
5.935200E-01
Non Drinker-vs-Weekly Drinker
8.896800E-01
Non Drinker-vs-Occasional Drinker
1.072230E-01
Non Drinker-vs-Social Drinker
1.233180E-01
Daily Drinker-vs-Weekly Drinker
5.824600E-01
Daily Drinker-vs-Occasional Drinker
6.144300E-02
Daily Drinker-vs-Social Drinker
6.493600E-02
Weekly Drinker-vs-Occasional Drinker
2.479400E-01
Weekly Drinker-vs-Social Drinker
2.525600E-01
Occasional Drinker-vs-Social Drinker
9.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.646500E-02
Normal-vs-Grade 2
1.368030E-02
Normal-vs-Grade 3
5.362900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.678200E-03
Grade 1-vs-Grade 3
2.539200E-03
Grade 1-vs-Grade 4
8.646500E-02
Grade 2-vs-Grade 3
4.621600E-01
Grade 2-vs-Grade 4
1.368030E-02
Grade 3-vs-Grade 4
5.362900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.701760E-02
Normal-vs-NonDiabetic
2.726100E-02
Diabetic-vs-NonDiabetic
5.920800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.677700E-02
Normal-vs-NoPancreatitis
2.734300E-02
Pancreatitis-vs-NoPancreatitis
5.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.142200E-02
Normal-vs-N1
3.512400E-02
N0-vs-N1
3.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.664000E-01
Normal-vs-TP53-NonMutant
9.504300E-02
TP53-Mutant-vs-TP53-NonMutant
1.140040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
